Pilar Nos-Nos Mateu
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 138 publications
Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control study.
Journal: Journal of Crohn's & colitis
Published: June 08, 2026
Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study.
Journal: Alimentary pharmacology & therapeutics
Published: March 14, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.
Journal: United European gastroenterology journal
Published: February 01, 2026
The TECCU-Based Telemonitoring Platform for Inflammatory Bowel Disease Is Cost-Effective: A Multicenter GETECCU Trial.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 13, 2025
GETECCU: a comprehensive national strategy for excellence in inflammatory bowel disease.
Journal: Therapeutic advances in gastroenterology
Published: November 05, 2025
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry.
Journal: United European gastroenterology journal
Published: October 23, 2025
Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkers.
Journal: Journal of Crohn's & colitis
Published: October 09, 2025
Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn's Disease: An Observational Study.
Journal: Biomedicines
Published: September 19, 2025
Real-world effectiveness of vedolizumab in refractory pouchitis: a focus on biomarker changes during intravenous to subcutaneous transition (POUCHIVED study).
Journal: Frontiers in immunology
Published: September 17, 2025
First Documented Case of Successful Dual Therapy With Upadacitinib and Mirikizumab for Multi-Refractory Ulcerative Proctitis.
Journal: Inflammatory bowel diseases
Published: April 06, 2025
Influence of Familial Inflammatory Bowel Disease History on the Use of Immunosuppressants, Biological Agents and Surgery in Patients with Pediatric-Onset of the Disease in the Era of Biological Therapies. Results from the ENEIDA Registry.
Journal: Journal of clinical medicine
Published: April 01, 2025
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics.
Journal: Frontiers in cellular and infection microbiology
Published: March 18, 2025
Last Updated: 09/26/2026